The QualityStocks Daily Friday, February 22nd, 2019

Today's Top 3 StockMarketWatch

MarketClub Analysis (ACHV) +84.36%

NetworkNewsWire (RNWR) +55.57%

QualityStocks (FTXP) +50.64%

The QualityStocks Daily Stock List

SusGlobal Energy Corp. (SNRG)

Simply Wall St, Penny Stock Hub, Trading View, Wallstreet Online, Market Screener, Dividend Investor, Barchart, Investors Hangout, Stocks News Feed, GuruFocus, Street Insider, Interactive Brokers, Law Insider, last10k, YCharts, Morningstar, and MarketWatch reported on SusGlobal Energy Corp. (SNRG), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

SusGlobal Energy Corp. is the developer of SusGro™, which is a pioneering pathogen free organic fertilizer. The Company is a renewables business centered on acquiring, developing, and monetizing a portfolio of proprietary technologies in the waste to energy and regenerative products application worldwide. SusGlobal Energy has its head office in Toronto, Ontario. The Company lists on the OTC Markets Group’s OTCQB.

SusGlobal Energy has the capability to provide a complete range of services for handling organic residuals. The Company has spent years attaining proprietary processes and combining different treatments. It also has many years of innovative experience and technical knowledge and thus can provide its clients with comprehensive solutions. SusGlobal Energy has projects in Belleville, Ontario; Hamilton, Ontario; and Florida.

SusGlobal Energy can, from beginning to end, offer in-depth knowledge, abundant experience and trailblazing technology for all a client’s needs in handling organic waste. Some of the Company’s work managing organic waste streams includes Anaerobic Digestion, Dry Digestion, Biogas Production, Wastewater Treatment, In-Vessel Composting, Source Separated Organics Treatment, Biosolids Heat Treatment and Composting.

The Company’s SusGro™ pathogen free organic fertilizer offers an economical, sustainable and highly effective alternative to traditional fertilization. SusGro™ is an organically-based, concentrated organic pathogen free liquid fertilizer product. It has a full complement of nutrients suitable for a broad spectrum of fertilization requirements.

In addition, SusGlobal Energy’s Earth’s Journey™ Compost enhances plant growth. The Company employs patented technology to transform organic waste into the most nutrient-rich organic compost, diverting organic waste from landfills and lessening Greenhouse Gas (GHG) emissions.

This week, SusGlobal Energy announced that its wholly-owned subsidiary, SusGlobal Energy Belleville Ltd. (SusGlobal Belleville), executed a non-binding Letter of Intent (LOI) for certain assets, including 39.44 acres of property located at 704 Phillipston Road, in Belleville, Ontario. Subject to the execution of an Asset Purchase Agreement (APA), the LOI sets out the terms, including the purchase price of USD$1,332,153 (CAD$1,767,250) in cash to be paid on closing, minus the sum of USD$54,274 (CAD$72,000) advanced by SusGlobal Energy to the seller on February 5, 2019.

If the APA is signed, SusGlobal Belleville will become the owner of the 39.44 land parcel and no more a lessee of the existing 13.88-acre section. SusGlobal Belleville will be expanding the site capacity to 70,000 tonnes per annum from the present 35,000 tonnes per annum composting facility to continue producing its Earth's Journey™ Compost, with an additional 50,000 tonnes per annum organic processing and transfer site approved under the existing Environmental Compliance Approval (ECA) and Site Plan.

Mr. Marc Hazout, Executive Chairman and President of SusGlobal Energy, stated, "We are very pleased to be able to enter into an LOI to purchase this large parcel of land with the ECA attached in order to expand our Belleville site to bring the Ontario, Quebec and New York State organic waste management systems to a sustainable level by diverting from landfills."

SusGlobal Energy Corp. (SNRG), closed Friday's trading session at $1.17, up 11.43%, on 64,654 volume with 38 trades. The average volume for the last 3 months is 11,250 and the stock's 52-week low/high is $0.25/$5.00.

chart

Prize Mining Corporation (PRZFF)

Investing News, The Street, Junior Mining Network, Science of Stocks, Small Cap Power, Stockhouse, Stock Market Watch, Market News Updates, Barchart, Wallet Investor, 4-Traders, OTC Markets, Business Insider, Trading View, and Penny Stock Hub reported previously on Prize Mining Corporation (PRZFF), and we also report on the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Prize Mining Corporation explores for and develops mineral properties. The Company’s flagship project is the Manto Negro Copper Project (Coahuila, Mexico). Additionally, it has its Kena & Daylight Gold project. An exploration stage company, Prize Mining is based in Calgary, Alberta.

The Manto Negro Copper Project has sedimentary stratabound oxidized and reduced “Red Bed type” copper deposits. The Manto Negro property consists of 17,659 hectares. It includes more than 35 known occurrences of copper mineralization.

Prize Mining received the NI 43-101 Technical Report for the Manto Negro property in Coahuila, Mexico from geological consultants, Norwest Corporation of Calgary, Alberta. The Technical Report includes a review of the regional and local geology, mineralization types and grades, exploration history and results, overall mineral potential and recommendations for more work. The report does not include any estimate of mineral resources nor reserves.

The Kena & Daylight Gold project is a large property with first-rate infrastructure. This Property comprises 9,000 hectares in southeastern British Columbia. The Property is 10 kilometers from the Town of Nelson. The Gold Mountain Zone and Kena Gold Zone are a porphyry gold deposit with high grade zones.

The Kena Property has an NI 43-101 resource of an indicated 481,000 ounces of gold and an inferred 1,318,000 ounces of gold. The Daylight claims have four historical producing mines with grades as high as 37 g/t gold. The Company’s focus on the Daylight Property is on four large gold-bearing targets.

Prize Mining announced this past December that step-out diamond drill holes at the Pilar Grande area of the Manto Negro Copper Project continues to intersect copper-silver mineralization. Drilling at the El Granizo site encountered complex faulting that is yet to be completely interpreted as to the impact on mineralization.

Also in December, the Company reported results from the Phase I and II diamond drill programs from the Kena Gold Project, positioned in the highly prospective Kootenay Boundary area near Nelson, British Columbia. The focus of the exploration program at the Kena Gold Project has been on the Toughnut Property. Drilling on Toughnut has intersected significant near surface gold mineralization. The higher grade intercepts demonstrate the potential for a much larger gold system on Prize Mining’s property.   

This week, Prize Mining provided an update on the results and success of its Phase 1 diamond drilling program at the Manto Negro Copper Project.

Mr. Michael McPhie, Prize Mining’s President and Chief Executive Officer, said, "We are very pleased to announce the completion of and results from our Phase 1 exploration drilling program at the Manto Negro Copper Project. We have tested just a small part of our 18,000 hectare property that contains some 35 surface copper showings over a 40 kilometer trend. These results provide us with confidence in the scale, grade and potential of this district size property and will guide our focus in the Phase 2 program that will begin in the weeks ahead."

Prize Mining Corporation (PRZFF), closed Friday's trading session at $0.0313, down 2.19%, on 2,401 volume with 3 trades. The average volume for the last 3 months is 27,077 and the stock's 52-week low/high is $0.019/$0.257.

chart

Cuentas, Inc. (CUEN)

InvestorsHub, AIStockFinder, Wallet Investor, MarketWatch, GuruFocus, Barchart, The Street, Investors Hangout, Market Screener, Street Insider, and PR Newswire reported on Cuentas, Inc. (CUEN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Cuentas, Inc. is a Financial Technology (FinTech) service provider listed on the OTC Markets’ OTCQB. The Company provides mobile banking, online banking, prepaid debit and digital content services to unbanked, underbanked and underserved communities. It utilizes technical innovation together with existing and emerging technologies to provide accessible, efficient and reliable mobile, new-era and traditional financial services to consumers. Cuentas has its corporate headquarters in Miami, Florida.

The Company’s business units are Cuentas Mobile and Cuentas Pinless. It offers mobile with its STI Mobile. With STI Mobile there are no commitments and flat rates. STI Mobile is good for the USA and more than 100 international destinations. Cuentas Mobile also offers its new data services plan and features high speed and reliable internet. It supports 3G/4G/LTE networks.

Cuentas Pinless offers TEL3 for making international calls. With TEL3, one can see their call history with the online account manager, call faster with the Speed Dial feature, and register their phone to make pinless calls. TEL3 offers low rates and a customer can save by getting recharge coupons directly on their phone, earning up to 5 percent of their total spending as reward points (free minutes). They will also get $10 worth of free minutes for every friend they refer.

In November 2018, Cuentas announced that its wholly-owned subsidiary Limecom, which specializes in wholesale international telecommunications services provided through Voice over Internet Protocol (VoIP), executed a $4 million, three-year, factoring facility with AEC Yield Capital, LLC, an affiliate of Advanced Energy Capital, LLC (AEC). Limecom has interconnections with greater than 100 Carriers globally and has provided more than 2 billion minutes of voice traffic.

Limecom produced revenue of more than $100M in fiscal 2017. In fiscal 2018, Cuentas' Income Statement will reflect 100 percent of the revenue of Limecom. AEC will provide an initial availability of $4 million for periodical purchasing of Limecom invoices. This facility will permit Limecom to grow its business unit considerably. Cuentas, which provides its mobile banking customers with Telecommunications Long Distance Rewards, will be using Limecom's International Network Legacy for these rewards.

This month, Cuentas announced that it rescinded its Stock Purchase Agreement with Limecom that will further decrease its debt by more than $3.3 Million. The Company’s debt reduction of $3.3 Million includes monies owed to Heritage Ventures Limited and employees of Limecom.

According to the Amendment to Stock Purchase Agreement executed January 29, 2019, a scheduled payment of $2 million to Heritage Ventures limited for the Stock Purchase Agreement pertaining to Limecom was cancelled. Pending loans to Heritage for $750,000 were exchanged for 90,000 shares of Cuentas. In addition, a number of executives, employees and contractors of Limecom converted $572,448 of compensation for 18,576 Cuentas shares, accepting a Company valuation of $50 million.

Cuentas, Inc. (CUEN), closed Friday's trading session at $1.71, even for the day. The average volume for the last 3 months is 912 and the stock's 52-week low/high is $0.81/$13.50.

chart

Medifocus, Inc. (MDFZF)

MoneyHub, OTC Markets, Wallet Investor, SmallCapVoice, Investor Place, Investor Network, Barchart, Street Insider, Financial Content, Trading View, MarketWatch, and otc.Watch reported beforehand on Medifocus, Inc. (MDFZF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Medifocus, Inc. has a portfolio of medical technologies that use patented Focal Thermal Technology to treat conditions ranging from Prostate Diseases to Breast Cancer. The Company’s portfolio of medical products includes thermotherapy systems for the treatment of Benign Prostatic Hyperplasia (BPH) and breast cancer. OTCQB-listed, Medifocus is based in Columbia, Maryland.

The Company owns two technology platforms with approximately 100 issued and pending U.S. and worldwide patents. One platform is the “Endo-thermotherapy Platform”. The other platform is the “Adaptive Phased Array Microwave Focusing Platform”.

Based on these proprietary technology platforms, Medifocus has developed two advanced therapeutic products. One is the Prolieve® system for the treatment of BPH. The other is the Adaptive Phased Array (APA)-1000 system for the treatment of breast cancer.

The Prolieve® Thermodilatation™ System provides symptomatic relief to men with Benign Prostatic Hyperplasia (BPH) via a simple, 45-minute, in-office treatment. Prolieve® is Food and Drug Administration (FDA) and Medicare approved for treating symptomatic BPH with more than 100,000 cases performed in the U.S. alone, and with proven long-term safety, efficacy, and durability. The purpose of the Prolieve system is to provide a relatively painless and effective alternative to drug therapy, and also certain types of surgical procedures to treat the symptoms of BPH.

Medifocus’ Heat Activated Gene Therapy, exclusively licensed from Duke University, aims at using the Company’s Focal Thermal Technology to enhance selective expression of therapeutic genes injected intratumorally to optimize cancer cell killing while lessening systemic side effects.

The APA 1000 Breast Cancer Treatment System developed by the Massachusetts Institute of Technology (MIT) has been shown in Phase 2 clinical trials to offer substantial additional shrinkage of the sizes of breast cancer in combined ChemoThermal therapy versus Chemotherapy alone. Additionally, it was shown to be effective in reducing margin positivity when patients were treated with APA 1000 before lumpectomy.

Last month, Medifocus announced that its Prolieve® Thermodilatation™ procedure for the treatment of BPH have been performed and reimbursed by insurance carriers in Hong Kong.

Dr. William Jow, said, “We are pleased that our efforts, together with the contribution from our Asian partners, are starting to yield tangible financial results from Prolieve® sales. Through our resolution in promoting Prolieve® in Asia and after having presented at three major international conferences within the past 16 months, I would like to see Prolieve® sales start to pick up in the near future both domestically and internationally.  We are pleased to enter the fast-growing Asia markets where BPH and cancers of the prostate and breast are quickly becoming major public health concerns.”

Medifocus, Inc. (MDFZF), closed Friday's trading session at $0.0274, even for the day. The average volume for the last 3 months is 16,643 and the stock's 52-week low/high is $0.0061/$0.0378.

chart

Nano One Materials Corp. (NNOMF)

NetworkNewsWire, Private Capital Newswire, Charts and Trends, Penny Stock Tweets, Stockhouse, Insider Tracking, Wallmine, Central Charts, GuruFocus, Dividend Investor, MarketWatch, Investors Hangout, OTC Markets, Market Screener, Capital Cube, Wallet Investor, Canadian Insider, Barchart, 4-Traders, and Morningstar reported earlier on Nano One Materials Corp. (NNOMF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Nano One Materials Corp. is developing patented technology for the low-cost production of high-performance battery materials used in electric vehicles, energy storage and consumer electronics. The Company’s mission is to establish its patented technology as a top platform for the worldwide production of a new generation of nanostructured composite materials. Nano One Materials has its headquarters, laboratory, and pilot facility in Burnaby, British Columbia and also has an office in Vancouver, British Columbia.

At present, the Company has active contribution agreements with the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP), Sustainable Development Technology Canada, and the Automotive Supplier Innovation Program – all programs of the Government of Canada. En bloc, these funding sources are projected to extend Nano One’s operating capital into Q1 2020.

The processing technology addresses important supply chain constraints through enabling wide-ranging raw materials specifications for use in lithium ion batteries. The process can be configured for a range of diverse nanostructured materials. Furthermore, it has the flexibility to shift with developing and future battery market trends and a varied range of other growth opportunities.

The novel three-stage process utilizes equipment common to industry. Nano One Materials has constructed a pilot plant to demonstrate high volume production and to optimize its technology across a range of materials. The core technology assembles low-cost raw materials in solution (including lithium, cobalt, magnesium) at high rates of production, before industrial driers and kilns complete the reaction.

This three-stage process can produce many types of ceramic powders. It is already being engineered, with industrial partners NORAM and BC Research, for high volume production and fast commercialization.

Nano One Materials has entered into a Joint Development Agreement with Saint-Gobain. The objective of this collaboration is to enhance high temperature processing of Nano One’s lithium ion battery materials. The two companies will work in collaboration, under the joint development agreement, to enhance the performance of its respective materials. Saint-Gobain produces a wide variety of construction and high-performance materials for applications in automotive, aerospace, health, and energy.

Nano One Materials has also entered into a Joint Development Agreement with Pulead Technology Industry. The Goal is to develop, evaluate, and optimize scaled up production of Pulead’s lithium iron phosphate (LFP) cathode materials utilizing Nano One’s technology, for use in lithium ion batteries. Licensing and commercialization opportunities will also be explored as part of this collaboration.

Last week, Dr. Stephen Campbell, CTO at Nano One Materials, announced the recent issuance of a patent in China. The Company now has 11 patents issued worldwide with Chinese patent ZL2014800279145 being directed to improved lithium ion batteries, using cathode materials made by Nano Ones’ patented process.

Dr. Stephen Campbell has been invited to speak at the Bank of Montreal’s 28th Global Metals and Mining Conference in Hollywood, Florida. Dr. Campbell will be speaking together with Kimberly Berman, BMO’s Special Projects Analyst specializing in battery chemistry, as part of the “Battery 101 – Intro to New Technology Session” in Ballroom C from 12:30pm – 1:30pm EST on Sunday, February 24, 2019. The session will introduce attendees to trends in lithium ion battery technology and raw materials.

Nano One Materials Corp. (NNOMF), closed Friday's trading session at $1.165, up 6.58%, on 9,759 volume with 23 trades. The average volume for the last 3 months is 11,280 and the stock's 52-week low/high is $0.7174/$2.03.

chart

Nutriband, Inc. (NTRB)

Market News Updates, Penny Stock Hub, Morningstar, Insider Monkey, Simply Wall St, GuruFocus, Barchart, InsiderMole, 4-Traders, The Street, Stockopedia, OTC Markets, MarketWatch, InvestorsHub, Stockhouse, last10k, Market Screener, and Stockwatch reported previously on Nutriband, Inc. (NTRB), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Nutriband, Inc. is a health and pharmaceutical Company listed on the OTC Markets Group’s OTCQB. The basis of all its products is around the science of Transdermal /Topical technologies. Nutriband Life Sciences is the pharmaceutical division of Nutriband, Inc. A Nevada corporation, Nutriband has its corporate office in Orlando, Florida.

The design of Nutriband’s products is on the principle that molecular combinations can be absorbed not only orally but also via the skin. Because of the intake method, all of the Company’s products contain nothing but the bare essential ingredients. This is because there is no need for binders, fillers or unwanted animal by-products such as gelatine.

The Nutriband Life Sciences division concentrates on the development, research and marketing of unique drug delivery systems. At present, its drug pipeline is in formulation, feasibility, and pre-clinical evaluation.

Last year, Nutriband acquired 4P Therapeutics, Inc. 4P Therapeutics becomes the Pharmaceutical and Development arm of Nutriband. 4P Therapeutics has a specific emphasis on Transdermal and Topical Technologies, prescription drugs, as well as clinical development.

Included in the acquisition of 4P Therapeutics’ Intellectual Property (IP) Portfolio is Defent™ abuse deterrent patch technology. This is an opioid abuse deterrent platform. It is for the transdermal delivery of opioid-based medications. Defent™ reduces the risk of abuse and misuse, creating a safer treatment for patients.

In September of 2018, Nutriband signed the definitive acquisition agreement to acquire Carmel Biosciences, Inc. According to this deal, Nutriband acquires the NDA and ownership rights to Food and Drug Administration (FDA) approved Prexxartan™, the ownership and rights to develop and market Carmel's pipeline including CAR-509, CAR-510, CAR-511 and CAR-512 now in Pre IND phase, and rights to Carmel's clinically tested nutraceutical line.

Recently, Nutriband announced that the United States Patent and Trademark Office (USPTO) granted the Company's request for Prioritized Examination (Track One) of the U.S. patent application for "Abuse and Misuse Deterrent Transdermal System" submitted by its subsidiary, 4P Therapeutics LLC.

Track One gives Nutriband's application special status with fewer requirements than the present accelerated examination program and without having to perform a pre-examination search. Nonetheless, the application still needs to be reviewed by the USPTO. Moreover, the grant of Track One status does not mean that a patent will be granted.

Nutriband, Inc. (NTRB), closed Friday's trading session at $8.96, up 0.11%, on 400 volume with 1 trade. The average volume for the last 3 months is 440 and the stock's 52-week low/high is $3.55/$12.69.

chart

Provectus Biopharmaceuticals, Inc. (PVCT)

Top Stock Analysts, Club Penny Stocks Network, The Street, Streetwise Reports, All Penny Stocks, Stock News Now, Wise Alerts, plrinvest, Investors Underground, Real Pennies, PennyStocks24, Top Penny Stock Movers, Street Insider, Street Authority Daily, and The Microcap News reported previously on Provectus Biopharmaceuticals, Inc. (PVCT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Provectus Biopharmaceuticals, Inc. is a clinical-stage oncology and dermatology Biopharmaceutical Company. It is developing new therapies for the treatment of solid tumor cancers and dermatologic diseases. The Company`s investigational oncology drug is PV-10. PV-10 is an oncolytic immunotherapy enrolling patients in Phase 3 clinical trials for metastatic melanoma. Provectus Biopharmaceuticals has its head office in Knoxville, Tennessee.

PV-10 is an ablative immunotherapy under investigation in solid tumor cancers. PV-10 is a 10 percent solution of small molecule and halogenated xanthene Rose Bengal. It undergoes administration through direct injection into solid tumor cancers, including melanoma, liver, and breast. It is not designed to rely on a single pathway, receptor or antigen to work. There is no known resistance.

The intention of PV-10 is to kill only diseased cells upon injection into tumors. Provectus Biopharmaceuticals has received orphan drug designations from the Food and Drug Administration (FDA) for its melanoma and hepatocellular carcinoma indications. The Company completed Phase 2 trials of PV-10 as a therapy for metastatic melanoma, and of PH-10 as a topical treatment for atopic dermatitis and psoriasis.

PH-10 is a topical investigational drug for dermatology and is a topical hydrogel formulation. It yields selective delivery of rose bengal disodium to epithelial tissues. Regarding PH-10 for psoriasis and atopic dermatitis, a mechanism of action study is underway to measure the clinical and cellular response to PH-10's active investigational agent. A total of 226 subjects have been treated with PH-10 in Phase 1 or Phase 2 Clinical Trials.

Provectus Biopharmaceuticals announced this past November that it was granted orphan drug designation (ODD) by the FDA for small molecule oncolytic immunotherapy PV-10 for the treatment of neuroblastoma. This is a non-Central Nervous System (CNS) pediatric solid tumor. Intratumoral injection of PV-10 can yield immunogenic cell death (ICD) in solid tumor cancers and stimulate tumor-specific reactivity in circulating T cells. ODD status was earlier granted to PV-10 for the treatments of metastatic melanoma in 2007 and hepatocellular carcinoma (HCC) in 2013.

Recently, Provectus Biopharmaceuticals announced that orphan drug designation (ODD) status was granted by the FDA to small molecule oncolytic immunotherapy PV-10 for the treatment of ocular melanoma (to include all melanoma disease affecting the eye and orbit). The FDA grants ODD status to medicines intended for the treatment, diagnosis or prevention of rare diseases or disorders that affect less than 200,000 people in the United States. ODD status qualifies companies for certain benefits. These benefits include seven years of market exclusivity following marketing approval, tax credits on U.S. clinical trials, eligibility for orphan drug grants, as well as waiver of certain administrative fees.

Also recently, Provectus Biopharmaceuticals and the Pediatric Oncology Experimental Therapeutics Investigators Consortium (POETIC) announced that OncoTargets and Therapy (OTT) published preclinical results from in vitro and animal tumor model studies on PV-10 for the treatment of neuroblastoma. POETIC is a group of 10 top-tier academic medical centers developing new pediatric cancer therapies.

The work was led by Dr. Aru Narendran and his team at the University of Calgary’s POETIC Preclinical and Drug Discovery Laboratory. Prior preclinical and clinical studies by other researchers have shown that intratumoral injection of PV-10 can yield immunogenic cell death in adult solid tumors and stimulate tumor-specific reactivity in circulating T cells.

According to the POETIC authors, “Our studies provide preclinical proof-of-concept data on the efficacy of PV-10 in neuroblastoma. Mechanistically, we have found that PV-10 acts by disrupting lysosomes, inducing cell cycle changes and initiating cell death by apoptosis. We have also identified several commonly used treatments with which PV-10 shows synergistic anti-tumor activity. Furthermore, we have validated the efficacy of PV-10 in vivo, using neuroblastoma xenograft mouse experiments.”

Provectus Biopharmaceuticals, Inc. (PVCT), closed Friday's trading session at $0.0598, up 4.91%, on 375,948 volume with 16 trades. The average volume for the last 3 months is 301,906 and the stock's 52-week low/high is $0.029/$0.084.

chart

American Resources Corporation (AREC)

NetworkNewsWire, InvestorsHangout, Coal Zoom, OTC Markets, MarketWatch, OilandGas360, Penny Stock Hub, Stockwatch, Barchart, Stockhouse, Simply Wall St, and Street Insider reported on American Resources Corporation (AREC), and today we report on the Company, here at the QualityStocks Daily Newsletter.

American Resources Corporation engages in diversified energy services. This includes mining, processing, and logistics. Its chief focus is on traditional energy sources such as coal and oil and gas. The Company formerly went by the name NGFC Equities, Inc. It changed its corporate name to American Resources Corporation in February of 2017. OTCQB-listed, American Resources is based in Fishers, Indiana.

American Resources centers on acquiring and developing low cost, asset rich operations. It concentrates on the extraction, processing, storage and distribution of raw material for industrial purposes. The Company plans to expand its business through continuing to develop its currently leased properties and further expanding its processing and logistics business. Additionally, it plans to expand its business through the pursuit of strategic acquisitions.

Markets that American Resources centers on include coal operations; LNG (Liquefied Natural Gas) storage and distribution; oil and natural gas production & reserves; and new energy technologies. Concerning coal operations, its emphasis is on vertically integrated coal operations. This includes coal extraction, coal wholesaling, and distribution.

American Resources announced in April of this year that, through its wholly-owned subsidiary Quest Energy, Inc. and McCoy Elkhorn Coal LLC, it entered into an agreement to acquire certain coal assets from Empire Coal Processing, LLC. This includes the presently operating PointRock Surface Mine in Phelps, Pike County, Kentucky. With the agreement, McCoy Elkhorn Coal immediately assumes operational control of the PointRock Mine and the associated leases, permits, government approvals, reclamation bonds, and equipment.

American Resources also announced that via Quest Energy and Knott County Coal LLC, it entered into an agreement to acquire an active surface mining operation focused on re-mining a coarse disposal area in Wayland, Floyd County, Kentucky. With the agreement, Knott County Coal immediately assumes ownership of all permits, leases, government approvals, and reclamation bonds associated with the Wayland, Kentucky refuse area.

American Resources, by way of Quest Energy and Deane Mining LLC, recently began operations at its Razorblade Surface mine in Letcher County, Kentucky. This is American Resources fifth mine brought into production in the last two years since acquiring and restructuring an asset base throughout the industry's most recent downturn to operate on a more efficient cost structure.

American Resources, via its wholly-owned subsidiary, Quest Energy, is focused on growing coal production in the Central Appalachian Basin. Metallurgical coal production accounts for about 70 percent of the Company’s Revenue, with gross target margins of roughly 25 percent. As its business grows, company-wide, it anticipates metallurgical coal to be a majority of its coal production, and targeted margins for all the Company’s operations to be in the 24 percent to 29 percent range.

Recently, American Resources commenced production on its Razorblade Surface mine, a Greenfield project in manifold coal seams. This includes the Hazard 4 Rider, Whitesburg, Amburgy, and Hamlin coal seams. At present, the Company operates this mine as a contractor model - the cost of coal extraction is fixed on a "per-ton" basis. The coal produced from this mine is trucked directly to the preparation plant or rail loadout at American Resources’ Deane Mining subsidiary, less than a mile from the mine.

American Resources, via its wholly-owned subsidiaries Quest Energy and McCoy Elkhorn Coal, announced it entered into a coal processing and transloading agreement with an international energy and commodity trading company. With this agreement, American Resources will provide third-party coal processing, storage, and rail loading services at one of its two processing facilities located at the Bevins Branch coal processing complex situated in Pike County, Kentucky. The two processing facilities at McCoy Elkhorn Coal are Bevins 1, an 800 ton-per-hour modern coal wash plant, and Bevins 2, a 500 ton-per-hour modern coal wash plant.

American Resources Corporation (AREC), closed Friday's trading session at $3.9805, up 2.06%, on 12,310 volume with 20 trades. The average volume for the last 3 months is 4,361 and the stock's 52-week low/high is $0.4603/$14.00.

chart

CLS Holdings USA, Inc. (CLSH)

TryBestPennyStocks, PennyPickAlerts, Penny Stock Professor, HotStockProfits, Beacon Equity Research, InvestorSoup, WINNINGOTC, Penny Stock Craze, Penny Stocks Finder, Stock Preacher, SuperStockTips, Fortune Stock Alerts, MoneyTV, Stock Commander, Equity Observer, Value Penny Stocks, eliteotc, SMS Penny Picks, Wall Street Beauties, SmallCapAllStars and Traders350 reported on CLS Holdings USA, Inc. (CLSH), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

CLS Holdings USA, Inc. is a development stage diversified cannabis company. CLS stands for "Cannabis Life Sciences," in recognition of its patent pending proprietary method of extracting different cannabinoids from the marijuana plant and converting them into a higher quality and quantity of products. CLS Holdings USA specializes in the extraction and conversion of cannabinoids. It is shifting its strategy to becoming a fully licensed integrated cannabis producer and retailer in the States of Nevada and other western States. CLS Holdings USA has its headquarters in Boulder, Colorado.

CLS’s business model includes licensing operations, processing revenue, processing facilities, sale of products, brand creation, and consulting services. The Company’s mission is to be the industry leader in the extraction, conversion and marketing of cannabinoid oils, wax, edibles, and shatter through taking advantage of its proprietary extraction methods and conversion processes.

CLS Labs took its first step toward commercializing its proprietary methods and processes through entering into an arrangement in Colorado on April 17, 2015. It entered into an arrangement through CLS Labs Colorado to, among other things, license its proprietary technology, methods, and processes to PRH in exchange for a fee; and construct a processing facility and lease such facility, including equipment, to PRH.

CLS will agree to build out a processing facility and subsequently lease the facility and equipment to the client for what will usually be a 10-year term. The client will be required to enter into an agreement of equal length to license CLS’s proprietary technology, methods, and processes exclusively for use in the processing facility.

CLS’s plan is to monetize the extraction method and produce Revenues through the licensing of its proprietary methods and processes to others, as in the Colorado Arrangement, the processing of cannabis for others, and the purchase of cannabis and the processing and sale of cannabis-related products.

CLS Holdings announced in December of 2017 that it entered into a definitive agreement to acquire Oasis Cannabis. Oasis has established itself as one of the top marijuana retailers in Nevada, offering in-store and delivery service to its customers. Oasis is a fully-integrated company. It provides grow, extraction, and conversion services, complete with a retail dispensary business.

Recently, CLS Holdings USA announced the successful closing of its acquisition of Oasis Cannabis. CLS is now active in the legalized cannabis market in Las Vegas, Nevada, producing $850,000 in gross monthly Revenue. CLS plans to triple the grow production capacity over the remainder of 2018 and into 2019.

CLS has the funds in place to complete the build out of its Las Vegas cultivation and production facility. Moreover, the Company will use a portion of the funds to update its existing Oasis Cannabis dispensary location and improve its signage.

CLS Holdings USA, Inc. (CLSH), closed Friday's trading session at $0.3998, up 39.30%, on 1,040,286 volume with 282 trades. The average volume for the last 3 months is 218,009 and the stock's 52-week low/high is $0.259/$1.35.

chart

Bimini Capital Management, Inc. (BMNM)

Zacks, Stockopedia, Information Vine, OTC Markets, InvestorsHub, MarketWatch, and Stockhouse reported on Bimini Capital Management, Inc. (BMNM), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Bimini Capital Management, Inc. chiefly invests in mortgage-backed securities (MBS) in the U.S. A specialty finance company, Bimini is an asset manager. The Company OTCQB-listed invests primarily in residential mortgage-related securities issued by the Federal National Mortgage Association (Fannie Mae), the Federal Home Loan Mortgage Corporation (Freddie Mac), and the Government National Mortgage Association (Ginnie Mae).

Formed in 2003, Bimini Capital Management is headquartered in Vero Beach, Florida. The Company formerly went by the name Opteum, Inc. It changed its corporate name to Bimini Capital Management, Inc. in September 2007.

Bimini Capital Management’s goal is to earn returns on the spread between the yield on its assets and its costs. This includes the interest expense on the funds it borrows.

Bimini also generates a considerable portion of its revenue serving as the manager of the MBS portfolio of Orchid Island Capital, Inc.  Orchid Island Capital is a publicly-traded real estate investment trust (REIT) (NYSE: ORC).

Bimini Capital Management, as manager, is responsible for administering Orchid Island Capital’s business activities and daily operations.  With this management agreement, Bimini Advisors provides Orchid with its management team. This includes its officers, along with suitable support personnel. Additionally, Bimini maintains a common stock investment in Orchid.

Furthermore, Bimini Capital Management manages the portfolio of its wholly-owned subsidiary, Royal Palm Capital, LLC. Royal Palm Capital is managed with an investment strategy alike to that of Orchid Island Capital.

Recently, Bimini Capital Management announced results of operations for the three-month period ended June 30, 2018. The Company realized Net Income of $0.2 million, or $0.02 per common share. Book value per share was $4.15.

Bimini’s results for the quarter included Advisory Services Revenue of $2.0 million, Interest and Dividend Income of $2.4 million, Interest Expense of $1.3 million, Net Realized and Unrealized Losses of $1.1 million, Operating Expenses of $1.7 million and an Income Tax provision of $0.1 million.

Bimini Capital Management, Inc. (BMNM), closed Friday's trading session at $1.99, even for the day, on 2,507 volume with 7 trades. The average volume for the last 3 months is 2,913 and the stock's 52-week low/high is $1.81/$2.69.

chart

Petrolia Energy Corp. (BBLS)

MarketWatch and Market Exclusive reported on Petrolia Energy Corp. (BBLS), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Petrolia Energy Corp.’s chief focus is utilizing cutting-edge technology and the implementation of its own pioneering, proprietary technologies to improve the recoverability of existing oil fields. The Company’s team of experts has a first-rate record of converting oil fields into compliant, producing, and profitable entities. Petrolia’s main objectives are to locate undervalued assets, identify properties with resolvable environmental and mechanical issues and lessening lift costs resulting in increased shareholder value.

Petrolia Energy has its headquarters in Houston, Texas. The Company formerly went by the name Rockdale Resources Corp. A domestic oil exploration and production enterprise, Petrolia Energy’s shares trade on the OTC Markets Group’s OTCQB.

The Company concentrates on new oil wells in established areas of oil production. Petrolia has more than 80 years of operational and management experience throughout the energy industry.

Petrolia Energy announced in October of 2016, that it purchased a 90 percent working interest (WI) by way of a purchase and sale agreement (PSA) and a share exchange agreement (SEA) with Jovian Petroleum Corp. and its subsidiaries, Jovian Resources, LLC and SUDS Properties, LLC, increasing its ownership to 100 percent WI for the Slick Unit Dutcher Sands (SUDS) field in Creek County, Oklahoma.

In 2017, Petrolia Energy completed the acquisition of a 60 percent net WI in the Twin Lakes San Andres Unit (TLSAU) lease, in Chaves County, New Mexico. This brings the Company’s total ownership of TLSAU to 100 percent.

On the whole, the TLSAU lease includes 4,864 gross and net acres; 2,292,903 barrels of 1P reserves; 44 existing vertical oil production wells, 12 that are presently producing; 44 existing injection wells for water flood and/or CO2 injection for enhanced oil recovery (EOR); wide-ranging surface infrastructure, and a dedicated Caprock well to supply future water flood operations.

Recently, further to Petrolia Energy’s press release dated December 5, 2017, the Company announced that it completed the acquisition of Bow Energy Ltd. Petrolia Energy acquired all of the issued and outstanding common shares in the capital of Bow. The Acquisition closed on February 27, 2018. Bow Energy is a Canadian based oil and natural gas company.

The acquired assets of Bow Energy comprise greater than 948,000 net acres onshore North Sumatra, Indonesia that consists of interests in five production-sharing contracts (PSCs) and one Joint Study Agreement (JSA) with the Indonesian government. These assets are surrounded by existing transportation infrastructure and significant discoveries by Repsol, ConocoPhillips and Chevron.

Petrolia Energy Corp. (BBLS), closed Friday's trading session at $0.14, up 12.72%, on 196,196 volume with 10 trades. The average volume for the last 3 months is 5,973 and the stock's 52-week low/high is $0.051/$0.448.

chart

International Frontier Resources Corporation (IFRTF)

MarketWatch, Stockhouse, Marketwired, 4-Traders, and Emerging Growth reported on International Frontier Resources Corporation (IFRTF), and we are reporting on the Company as well, here at the QualityStocks Daily Newsletter.

International Frontier Resources Corporation has a demonstrated record of accomplishment advancing oil and gas projects. The Company, by way of its Mexican subsidiary, Petro Frontera S.A.P.I de CV and strategic joint ventures (JVs) is advancing the development of petroleum and natural gas assets in Mexico. International Frontier Resources is based in Calgary, Alberta and the Company’s shares trade on the OTC Markets Group’s OTCQB.

International Frontier Resources (IFR) has projects in Canada and the United States, including the Northwest Territories and the State of Montana. In 2015, IFR created a JV company - Tonalli Energia - together with Grupo Idesa, one of Mexico’s largest petrochemical companies. IFR and Grupo Idesa are fully aligned; each owns a 50 percent share in Tonalli.

An industry-leading JV combines the strength of Grupo Idesa and IFR. Grupo Idesa is a well-established Mexican petrochemical company. In addition, IFR brings proven Canadian expertise to Mexico.

Block 24 Tecolutla establishes IFR’s Mexican JV as one of the first operators in Mexico and provides important insights into future rounds. Tecolutla is a very underdeveloped mature field with considerable upside potential.

Tonalli has submitted the regulatory applications and documentation, which will permit IFR to proceed with the drilling permit and operations at Tecolutla. The Tecolutla Block is in the Tampico-Misantla Basin within the State of Veracruz.

The Tecolutla Field is 7.2 square kilometers. It contains an oil reservoir at 2,340 meters or about 7,700 feet. The Tecolutla Block is a 60-80m gross pay carbonate reservoir on a structural high with proven oil production.

The expectation is that the existing wells at Tecolutla will exceed historic production numbers and peak initial production (IP) rates with the arrival of new recovering techniques, technology, and expertise to be undertaken by Tonalli.

Recently, International Frontier Resources announced that it received total proceeds of $2,561,045 from the exercise of warrants by members of the Executive and Technical team, Board of Directors and investment community. The Company issued an additional 24,961,880 common shares from its Treasury via the conversion of these warrants to shares.

Mr. Steve Hanson, International Frontier Resources’ President and Chief Executive Officer, stated, “We are pleased to have received a considerable investment in our business from our team, board members and the investment community. This additional capital will allow us to accelerate our business, further our development plans at Tecolutla and participate in future bid rounds in Mexico."

International Frontier Resources Corporation (IFRTF), closed Friday's trading session at $0.0644, up 9.15%, on 17,750 volume with 5 trades. The average volume for the last 3 months is 21,035 and the stock's 52-week low/high is $0.0516/$0.2559.

chart

Dakota Territory Resource Corp. (DTRC)

OTC Markets Group, Innovative Marketing, and UltimatePennyStock reported earlier on Dakota Territory Resource Corp. (DTRC), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.

Dakota Territory Resource Corp.’s emphasis is on the acquisition and responsible exploration and development of high caliber gold properties in the Black Hills of South Dakota. The Company maintains 100 percent ownership of three mineral properties. These include the Blind Gold, City Creek, and Homestake Paleoplacer Properties. All of these are in the heart of the Homestake District. Dakota Territory Resource is based in Reno, Nevada and the Company lists on the OTC Markets.

The Blind Gold Property is Dakota’s flagship property. It is a target for Tertiary-aged and Iron-formation gold mineralization. The Blind Gold Property is around four miles northwest and on structural trend with the historic Homestake Gold Mine. The Homestake Gold Mine produced roughly 40 million ounces of gold through its 125-year production history. It is the largest iron-formation-hosted gold deposit in the world.

In March of last year, Dakota Territory Resource announced that its intention is to continue its sampling program along trend of the zone of high grade gold mineralization identified by the first pass surface sampling program conducted on its 100 percent owned Blind Gold Property. The program identified a zone of high-grade gold mineralization in the Mississippian-age Pahasapa Limestone on the surface, with a peak gold assay value of 9.44 grams per tonne. The Company is preparing for drilling in the Homestake Gold District of South Dakota.

Its City Creek Property is a target for Homestake iron-formation gold mineralization. City Creek consists of 21 unpatented lode mining claims located one-mile northeast of the Homestake Open Cut and one-mile northwest of the City of Deadwood.

The Homestake Paleoplacer Property consists of 13 unpatented lode mining claims positioned one-mile north of the Homestake Open Cut. Dakota Territory Resource based the acquisition of its Black Hills property position on more than 44 years of combined mining and exploration experience in the Homestake District.

This past April, Dakota Territory Resource announced that it entered into agreements with Trucano Novelty, Inc. to acquire a combination of surface and mineral title to 284 acres located in the Homestake District of the Northern Black Hills of South Dakota. Dakota’s property acquisition is consistent with its business development strategy of expanding its high quality mining interests within the Homestake District. The Company now holds approximately 3,341 acres in the core of the district.

In May, Dakota Territory Resource announced that its research of historic data identified high grade gold mineralization under Dakota Territory's recently acquired property at Maitland. In the 1960's, Homestake Mining Company collared diamond drill hole # 6091A at the western fringe of the Maitland Mine and drilled at a -50-degree angle to the southwest across Dakota Territory's recent land acquisition.

The hole was drilled to a total depth of 137.5 meters. This includes an 11.3-meter-long intercept from 111.2 meters to 122.5 meters down hole containing 5.18 grams per tonne gold. The gold intercept in diamond drill hole #6091A was in the Precambrian Poorman - Homestake - Ellison stratigraphic sequence, which hosted the 40 million-ounce Homestake gold deposit situated just over 4 km to the south.

Dakota Territory Resource Corp. (DTRC), closed Friday's trading session at $0.075, up 7.14%, on 1,420 volume with 3 trades. The average volume for the last 3 months is 49,460 and the stock's 52-week low/high is $0.0251/$0.1917.

chart

Zynex, Inc. (ZYXI)

SmarTrend Newsletters, FeedBlitz, BUYINS.NET, TaglichBrothers, Zacks, FNNO Newsletters, Daily Markets, and SmallCapVoice reported earlier on Zynex, Inc. (ZYXI), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Zynex, Inc. is a medical technology company listed on the OTC Markets Group’s OTCQB. The Company specializes in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neuro diagnostics, cardiac and blood volume monitoring. Furthermore, Zynex is developing a new blood volume monitor for use in hospitals and surgery centers.  Established in 1996, Zynex is based in Lone Tree, Colorado.

The Company markets and sells its own design of electrotherapy medical devices utilized for pain management and rehabilitation. In addition, Zynex markets and sells its proprietary NeuroMove device designed to help recovery of stroke and spinal cord injury patients.  Its product lines are completely developed, Food and Drug Administration (FDA)-cleared, and commercially sold globally.  Zynex engineers, manufactures, markets and sells its own design of medical devices in three subsidiaries.

Zynex Medical is a provider of electrotherapy products for home use. Zynex Monitoring Solutions develops products for cardiac monitoring for use in hospitals. Zynex NeuroDiagnostics develops devices for EMG and EEG diagnostic purposes in the neurology clinic markets.

Zynex announced in March of 2015 that it submitted a Pre-Submission application to the FDA for its non-invasive Blood Volume Monitor, CM-1500. Zynex’s belief is that this will be the first device to provide an indication of fluid balance and blood loss in the operating room or potential post-surgical internal bleeding in recovery.

The Company announced in September of 2015 that its wholly-owned subsidiary, Zynex Monitoring Solutions, filed an application with the FDA pursuant to Section 510(k) of the Food, Drug and Cosmetic Act for clearance of its new CM-1500 monitoring device.

This past June, Zynex announced the appointment of Mr. Dan Moorhead as its Chief Financial Officer (CFO). Mr. Moorhead has more than two decades of experience in an array of finance roles serving private and public companies. He is a CPA (Certified Public Accountant) and holds a B.B.A. in Accounting from the University of Northern Colorado.

Also in June, Zynex announced that ColoradoBiz Magazine recognized the Company in Top100 Public Companies in its May/June 2017 issue. Zynex was ranked 90th on 2016 revenue of $13.3 million. This is up from 93rd in 2015 on $11.6 million in revenue. The Company earlier announced estimated Q2 2017 revenue of $3.8 million and EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) of $650,000.

Zynex, Inc. (ZYXI), closed Friday's trading session at $5.426, up 0.48%, on 75,135 volume with 254 trades. The average volume for the last 3 months is 26,328 and the stock's 52-week low/high is $2.40/$5.50.

chart

The QualityStocks Company Corner

The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF)

The QualityStocks Daily Newsletter would like to spotlight The Flowr Corporation (FLWR).

By upholding its focus on exclusively providing premium cannabis products, the Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) is slated to excel in the ever-growing cannabis market. To view the full press release, visit: http://nnw.fm/T29Zd.

The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF), a Health Canada Licensed Producer (LP) of cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR), is an emerging Canadian cannabis leader founded by Medreleaf co-founder Tom Flow and a team of industry pioneers, successful start-up executives and top industry scientists. Flowr’s purpose-built cultivation facilities may be the most advanced in the industry, consistently generating high crop yields, delivering premium and ultra-premium cannabis products, and maximizing return on investment. The company also may be an R&D leader as it was selected by the Hawthorne Gardening Division of The Scotts Miracle-Gro Company as its exclusive Canadian cannabis R&D partner.

Flowr’s flagship facility, an 84,000-square-foot campus on seven acres in Kelowna, British Columbia, is engineered to grow premium cannabis in rooms that meet pharmaceutical industry production standards for cleanliness. This, along with exacting protocols designed by the Flowr team, enables Flowr to grow cannabis that meets Health Canada’s stringent standards without treating it with the taste- and smell-killing gamma irradiation that most other producers have to use to clean their product. Irradiating the plant – a process similar to pasteurizing food – impairs many of the important terpenes that provide the positive effects, flavors and scents of cannabis while strengthening unpleasant terpenes. Flowr’s products may deliver a better user experience, thus commanding premium prices.

Flowr’s cultivation facilities, built with proprietary, patent-pending systems, are designed to deliver yields targeted at 450 grams per square foot by the end of 2022, which is three times more efficient than the industry average of approximately 150 grams per square foot. By optimizing yield, the Company may produce significantly more cannabis flower on a smaller footprint than other producers, thus generating far high revenue per square foot and keeping costs much lower, leading to higher margins. The Kelowna facility is presently 20 percent operational with the remaining 80 percent slated to come online by early 2019. It is expected to produce up to 14,000 kg of premium, non-irradiated cannabis flower in 2019. With further enhanced yields and planned expansion of production facilities on the campus, Flowr will reach a total capacity of 60,000 kg annually in 2022.

Leading Flowr’s cultivation program is industry pioneer, company co-founder and Flowr president Tom Flow. Flow is widely recognized for his cannabis thought leadership and expertise building and operating cannabis cultivation facilities. Flow also co-founded MedReleaf and designed, built and set up SOPs for their flagship Marcum cultivation facility. Marcum has continued to be perhaps the most productive facility in the country prior to the Flowr flagship facility. Long one of Canada’s most efficient and profitable LPs, MedReleaf was acquired by Aurora for approximately C$3 billion. Flow and his team have designed and built a total of 17 cultivation facilities and secured three producer’s licenses under various Canadian regulatory regimes.

In March 2018, Flowr and the Hawthorne Gardening Division of The Scotts Miracle-Gro Company – a world leader in lawn and garden products – announced an exclusive strategic R&D alliance. After evaluating numerous Canadian LPs, Hawthorne chose to partner with Flowr based on the experience and expertise of the company’s cultivation and R&D teams and the company’s advanced growing capabilities.

Hawthorne will fund the construction of a 50,000-square-foot R&D facility that is integrated into Flowr’s Kelowna campus. This facility is North America’s first dedicated cannabis R&D facility focused on advancing cultivation techniques and systems. The facility will support researchers from both organizations and combine laboratories, indoor and greenhouse grow suites, training areas and genetics breeding areas in a single building. It is expected to open in early 2019. In addition to helping Flowr maintain its competitive advantage in cultivation, the company’s R&D program will keep it on the cutting edge of cannabis innovation.

Flowr is entering the market with three different brands to meet the growing demand for premium, non-irradiated cannabis in the medicinal and adult use markets:

  • FlowrRx, featuring premium quality medicinal cannabis that enables patients to live better, fuller lives. A dedicated Client Services team will provide patients with personalized support while an R&D team develops innovative flower strains and premium products targeted to specific conditions. Patient well-being is considered at every stage of the process – from genetic selection to harvest, trimming and curing techniques. FlowrRx and its team of passionate scientists and leading cultivation specialists are dedicated to advancing the scientific understanding of cannabis.
  • Flowr is the company’s premium recreational adult-use brand featuring an active, West Coast-inspired lifestyle for the cannabis connoisseur and enthusiast market. Through the continuous innovation of procedures and practices, Flowr’s talented team of experts is crafting premium products that deliver unparalleled experiences.
  • Ace Valley, an exclusive partnership with top-selling Ontario craft beer company Ace Hill, will bring Flowr’s premium product to the millennial and casual adult-use markets under the Ace Valley brand.

Flowr recently signed a Memorandum of Understanding with the British Columbia Liquor Distribution Branch, the province’s sole legal wholesaler of non-medical cannabis, to supply premium and ultra-premium flower to the province’s retail outlets. The company has agreements with several major medical distributors and is in discussions about retail distribution with additional provinces where it believes it can obtain prices commensurate with the quality of the Flowr products. The company is also evaluating other market opportunities including export.

Flowr is poised to become the pre-eminent indoor premium cannabis grower in Canada and one of the country’s top five LPs. The company’s focus on yield, quality and price point and its team’s ability to grow at scale should drive high margins, significant growth and strong return on investment.

The Flowr Corporation (TSX.V: FLWR), closed the day's trading session at $4.87, up 6.10%, on 157,659 volume with 244 trades. The average volume for the last 3 months is 86,829 and the stock's 52-week low/high is $2.74/$8.00.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (US:TGODF) is pleased to provide a detailed update on its Jamaican partner Epican Medicinals Ltd. ("Epican"). In June 2018, TGOD purchased 49.18% interest in Epican, a fully integrated Jamaican cannabis company with cultivation, extraction, manufacturing and retail distribution licenses. Significant progress has been made towards expanding cultivation, opening additional retail dispensaries, and establishing a leadership position in Jamaica's robust medical cannabis market. 

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $2.81075, up 0.03%, on 780,824 volume with 1,319 trades. The average volume for the last 3 months is 953,535 and the stock's 52-week low/high is $1.607/$7.894.

Recent News

chart

TransCanna Holdings Inc. (CSE: TCAN)

The QualityStocks Daily Newsletter would like to spotlight TransCanna Holdings Inc. (CSE: TCAN).

TransCanna Holdings Inc. (CSE:TCAN) (FSE: TH8) (“TransCanna” or the “Company”) is pleased to announce the execution of an LOI to lease a new 15,000 square foot facility currently under construction with a completion date of April 30th in Adelanto, CA.  This multi-faceted facility is intended to be one of four strategically located satellite facilities located throughout California.

TransCanna Holdings Inc. (CSE: TCAN) through its subsidiaries specializes in assisting clients who are cannabis farmers and manufacturers get recognized by end consumers who in turn purchase their products. TransCanna offers or will be offering services to support almost every aspect of the cannabis-related eco-system; from branding and design, to transportation and distribution, to marketing and sales.

California’s legalized adult-use recreational marijuana market opened for business January 1, 2018. The state’s Bureau of Cannabis Control is responsible for regulating all commercial activities in the state including cultivation, distribution and transportation. Moving cannabis products in the California marketplace is extremely challenging due to municipal and state laws and regulations, which can differ among cities and counties. Since cannabis remains illegal under federal law, Department of Transportation regulated companies are barred from participating in the market, which means companies looking to excel in the sector must hold a state-issued distributor license from the Bureau of Cannabis Control.

TransCanna has already entered into an Intellectual Property Rights and Royalty Agreement for the Track & Trace software platform required by the state of California. TCM Distribution, the operating company managed by TransCanna, has received a transportation and distribution permit from the city of Adelanto and a temporary transportation and distribution permit from the state of California. TransCanna has also executed a land lease to build a 10,000-square-foot transportation and distribution facility in Adelanto.

TransCanna is strategically creating a distribution network throughout California that places its facilities no further than a three-hour drive from most any client. The company is in the process of leasing or purchasing properly licensed and permitted warehouses strategically located throughout California along with new secure trucks, sprinter vans and/or armored vehicles.

TransCanna plans to create its own portfolio of branded products for the cannabis and hemp sectors. The company’s management team intends to translate the skills, knowledge and experience gained from a combined 60 years of branding and marketing experience in the music, professional sports and alcohol industries into TransCanna and the cannabis industry.

As part of the “TransCanna Way,” the company intends to manage most aspects of the supply chain from upper end procurement, branding, transportation and distribution, to marketing and sales.

Leading TransCanna as its CEO and chairman is James Pakulis, who has three decades of experience working with public and private entrepreneurial companies in a variety of emerging and high-growth sectors. He is formerly the president and a director of Lifestyle Delivery Systems Inc. (CSE: LDS) (OTCQB: LDSYF), a vertically integrated cannabis-related entity operating in California. Pakulis was chairman and CEO of General Cannabis Inc. which from 2010 to 2012 owned WeedMaps. Pakulis oversaw the company’s growth from zero to over $16 million in annual revenue in less than 24 months.

The company’s strategic advisors include individuals with extensive experience in branding, marketing, sales, distribution, production and supply chain management.

For additional information, call: (604) 609-6199

TransCanna Holdings Inc. (CSE: TCAN), closed the day's trading session at $2.73, up 5.00%, on 121,140 volume with 68 trades. The stock's 52-week low/high is $0.769/$2.90.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) was featured today in the 420 with CNW by CannabisNewsWire. As the marijuana industry has grown and become more widely accepted, many tech companies have introduced new products to enable the cannabis industry. Here are the four major AI products that marijuana businesses are deploying to boost sales and make ecommerce more successful.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECHTM technology to improve taste, remove odor, and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada, the largest-market states in the United States, and internationally. Lexaria has entered into a R&D partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea, and supplements. These brands include ViPova™ and TurboCBD™.

In 2015, Lexaria commissioned an independent third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation improve intestinal absorption as much as 500%. Lexaria has conducted multiple rounds of studies including in vivo and human clinical. In absorption studies conducted on rats, for example, Lexaria detected nicotine in the animal’s bloodstream just two minutes after it entered the stomach. In a randomized, double blinded human clinical study, cannabidiol (CBD) was measure in the human bloodstream at a 317% higher rate 30 minutes after swallowing a capsule processed with DehydraTECH than a non-enhanced capsule of equal strength.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: Hemp/CBD; Pharmaceutical; Cannabis; and Nicotine.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the end of 2018, the company’s patent portfolio includes 53 patent applications filed and pending in more than 40 countries around the world; and 10 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally in 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third-partners and has signed royalty deals with start-up companies as well as with a Fortune 100. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $1.38, up 1.51%, on 128,467 volume with 196 trades. The average volume for the last 3 months is 188,851 and the stock's 52-week low/high is $0.75/$2.43.

Recent News

chart

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

CEO Warren Wang of ChineseInvestors.com Inc. (OTCQB: CIIX) recently shared, on MoneyTV with Donald Baillargeon, his journey with the company since its founding in 1999 and his commitment to continually building success for decades to come. The full interview can be found at www.MoneyTV.net under past shows.

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed the day's trading session at $0.4651, up 1.11%, on 187,003 volume with 71 trades. The average volume for the last 3 months is 94,960 and the stock's 52-week low/high is $0.365/$1.25.

Recent News

chart

Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G)

The QualityStocks Daily Newsletter would like to spotlight Sproutly Canada, Inc. (SRUTF).

Sproutly Canada Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G) CEO Keith Dolo sat down with NetworkNewsAudio to share the company’s vision of becoming the leading supplier to the cannabis beverage and edibles market. Dolo believes that the company’s unique business model and positioning as a licensed producer and technology company have created a distinct advantage for Sproutly. To listen to the full interview, visit http://nnw.fm/o6H35.

Sproutly Canada, Inc. (OTCQB: SRUTF) (TSX.V: SPR) (FRA: 38G) is developing and bringing to market cannabis consumer products with a focus on beverages. The company’s core mission is to become the leading supplier of water-soluble cannabis solutions and bio-natural oils for brands in the emerging cannabis beverage and edibles market.

To make this happen, Sproutly acquired Infusion Biosciences to bring to market a patent-pending Aqueous Phytorecovery Process (APP) technology, a fundamental paradigm shift within the cannabis industry. Replacing traditional water-compatible solutions with true natural water solubility improves the body’s ability to utilize cannabinoids, making the effect of the cannabis almost immediate.

This revolutionary process doesn’t alter the cannabis compounds and provides an onset time and offset time that mimics the same effects as inhaled marijuana. That means consumers may feel effects in five minutes or less and be free from the desired effect in approximately 90 minutes—a vastly different ingestion pattern than current methods. In addition, the water-based cannabinoids can be mixed with other liquids and stay dissolved in those liquids. The application of water-soluble cannabis infusions has potential to be widespread in both medicinal and recreational cannabis sectors, giving Sproutly a distinctive edge in a market with untapped potential.

Sproutly’s business model is focused on processing rather than cultivating, which means its success is not constrained to growing its own cannabis. The company does own a Toronto-based, ACMPR-licensed facility designed and built with a focus on cultivating pharmaceutical-grade cannabis to produce and formulate the first natural, truly water-soluble cannabis solution. Its water-soluble ingredients and bio-natural oils will deliver revolutionary brands to international markets that are searching for well-defined commercial products.

Sproutly’s entrance in the cannabis market is perfectly timed as cannabis is moving towards mainstream acceptance. Potential users are, however, interested in consuming cannabis products as drinks and using it as oils rather than smoking. The potential cannabis beverage market is staggering, and with Sproutly owning the exclusive rights to APP technology in Canada, Australia, Jamaica, Israel and the entire European Union, the company is looking at significant international expansion opportunities.

Sproutly plans to capitalize on these international opportunities by executing on partnerships with local and globally established consumer brands to leverage their existing customer bases, expand brand loyalty, and assist with marketing and support distribution networks to deliver scientific breakthroughs with speed and efficiency?worldwide.

Management

Sproutly believes that talent drives growth. The company is committed to bringing together the best and brightest minds in the cannabis space to help with their mission to disrupt the global beverage and consumables market.

President, CEO and Director Keith Dolo recently served for more than 13 years with Robert Half, an S&P 500, NYSE-listed company. At Robert Half, Dolo held the position of vice president for more than eight years, as well as other senior roles in both operations and sales. He also sits on an advisory committee and a board position for two nonprofits in Vancouver, BC.

Chief Science Officer and Director Dr. Arup Sent has more than 35 years of experience in research and executive management at biotechnology and pharmaceutical companies. He was awarded a PhD in biochemistry from Princeton University and is a former faculty member at the National Cancer Institute and Scripps Research Institute. Sen is the inventor on five U.S. patents and numerous international patents and patent-pending applications.

Chief Financial Officer Craig Loverock is a chartered professional accountant with over 20 years of experience in accounting and finance roles in Canada, the United States and the United Kingdom. He has extensive expertise in public company reporting and transactional experience, having served as the senior financial advisor to the chairman at Magna International and acting as chief compliance officer and CFO for a private equity firm.

Head Grower Frank Han has over 12 years of experience in the horticulture industry. A previous master grower in a large commercial facility, Han has impressive expertise in all growing methods, techniques and procedures. He brings with him a wealth of knowledge in cloning, nutrient and overall plant management. Han will be in charge of the production team at Sproutly’s Toronto Herbal Remedies facility.

Sproutly Canada, Inc. (OTCQB: SRUTF), closed the day's trading session at $0.3025, up 0.50%, on 288,085 volume with 83 trades. The average volume for the last 3 months is 273,158 and the stock's 52-week low/high is $0.189/$1.875.

Recent News

chart

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ)

The QualityStocks Daily Newsletter would like to spotlight QMC Quantum Minerals Corp. (QMCQF).

Quantum Minerals (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) reported in a news release Thursday that drilling has begun at its wholly-owned Irgon Lithium Mine Project. To view the full press release, visit: http://nnw.fm/Fo39m.

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ) is a British Columbia based company engaged in the business of acquisition, exploration and development of natural resource properties. QMC’s focus is on creating shareholder value through strategic acquisition and development of high quality lithium, silver, gold, nickel, copper and zinc prospects.

QMC’s current properties are in the Canadian province of Manitoba, one of Canada’s most productive, centrally located mining regions. These resources include the Irgon Lithium Mine project and two Volcanic Massive Sulphide (“VMS”) properties – the Rocky Lake and Rocky-Namew known collectively as the Namew Lake District Project – which contain base metal-rich mineral deposits. Excellent access and well-developed mining infrastructure to the company’s wholly-owned Irgon Lithium Mine Project offers significant value and ramps up the near-term production schedule, putting QMC in a position to take advantage of rising lithium prices.

The region’s historic resource estimate of lithium is well documented in a 1956 Assessment Report developed by a previous owner, Lithium Corporation of Canada Ltd. The project’s historical resource estimate of 1.2 million tons grading 1.51% lithium-oxide over a strike length of 365 meters and to a depth of 213 meters is being updated by QMC through a detailed channel sampling and subsequent drill program.

North Face Software Ltd. recently created an interactive 3-D model of the Irgon Dike utilizing all historical data derived from past drilling and underground work. The 3-D model clearly demonstrates that exploration and underground development has only taken place on the central portion of the dike, leaving significant potential to quickly increase tonnage.

The company’s latest assay results, obtained from 144 channel samples at QMC’s Irgon Lithium Mine Project, provided encouraging and positive results that compare favorably with the historic assays. QMC has received a drill permit from the Sustainable Development Office of the Manitoba government and is in the process of requesting and assessing bids from drilling contractors. The company plans to begin a 2,000-meter drill program to confirm the historic lithium oxide assay results documented in the historic 1953-54 drill program.

QMC’s experienced leadership team includes specialists in mineral exploration, geology, engineering, new business development, marketing and investor relations. The company’s team of qualified advisors includes consultant Bruce E. Goad, P.Geo., who has 40 years of experience in mineral exploration in Canada, Argentina, Asia and Africa. As a Qualified Person, Goad has worked on numerous deposit styles including rare element pegmatites, porphyry, banded iron formation (BIF) gold deposits, skarn, greisens,  and VMS. He has a wide and varied skill set which includes precious, base, industrial and rare metal projects with a sharp focus on gold exploration. Goad is the author of several scholarly publications on pegmatite granites of the southeastern Manitoba region.

The market for lithium has surged over the past three years with prices per metric ton tripling. The world’s rising demand for portable power can easily been seen in the electric vehicle and mobile device industries – both of which use lithium-based, renewable batteries as a power resource. QMC’s high potential prospects and experienced management team, both in geology and corporate finance, put QMC and its shareholders in an excellent position to take advantage of the lithium, precious and base metals markets.

QMC Quantum Minerals Corp. (QMCQF), closed the day's trading session at $0.2425, up 4.27%, on 52,248 volume with 29 trades. The average volume for the last 3 months is 61,608 and the stock's 52-week low/high is $0.1155/$0.68.

Recent News

chart

BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT)

The QualityStocks Daily Newsletter would like to spotlight BriaCell Therapeutics Corp. (BCTXF).

BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT), a biotechnology company with a focus on immune-oncology, is expected to announce findings pertaining to the effectiveness and mode of action of its lead product candidate – Bria-IMT – at the 2019 ASCO-SITC Clinical Immuno-Oncology Symposium, according to a company press release (http://nnw.fm/4D2Ap). The key oncology conference will be taking place from February 28 to March 2, 2019, in San Francisco.

BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT), based in Berkeley, CA, and headquartered in Vancouver, British Columbia, is a clinical-stage biotechnology company focused on the development of targeted immunotherapy for advanced breast cancer.

BriaCell hopes to develop and market the first off-the-shelf personalized immunotherapy for the treatment of advanced breast cancer.

The results of two previous proof-of-concept clinical trials produced encouraging results in patients with advanced breast cancer. Most notably, one patient with breast cancer that had spread to other sites (metastatic cancer) responded to Bria-IMT™ with a substantial tumor shrinkage in multiple sites including the breast, the lung, soft tissues and even the brain. Similar observations have been confirmed more recently in additional patients, and BriaCell is developing BriaDX™ as a way to identify those patients most likely to respond.

BriaCell has recently completed recruitment of a Phase I/II study (NCT03066947) of Bria-IMT™, the Company’s lead product candidate, in advanced breast cancer patients showing an outstanding safety profile and excellent efficacy. BriaCell is currently enrolling advanced breast cancer patients in a combination therapy trial (NCT03328026) of Bria-IMT™ with Keytruda® (Keytruda® is a registered trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.) or Yervoy® (Yervoy® is a registered trademark of Bristol-Myers Squibb Company). For further information on the Phase IIa clinical trials, please visit trial NCT03066947 and trial NCT03328026.

BriaCell’s pipeline also includes Bria-OTS™, the first off-the-shelf personalized immunotherapy for advanced breast cancer; and, a companion diagnostic product BriaDX™. By using BriaDX™ to identify and treat the patients who would most likely benefit from their immunotherapies, BriaCell expects to personalize the treatment for the patients, and bring hope to thousands of cancer patients who currently have few-to-no treatment options.

Breast Cancer Statistics

The National Cancer Institute estimates that more than 265,000 new cases of female breast cancer will be diagnosed in the U.S. during 2018, and that more than 40,000 women in the U.S. will die from the disease. Approximately 12 percent of women will be diagnosed with breast cancer at some point during their lifetime, based on 2013-2015 data.

Using its novel technology platform and strong R&D capabilities, BriaCell believes it has the opportunity to address this market, as well as have the opportunity to develop immunotherapy candidates for other cancer indications.

The global cancer immunotherapy market is expected to reach nearly USD$203 billion by 2025.

BriaCell Therapeutics Corp. (BCTXF), closed the day's trading session at $0.07978, up 3.75%, on 5,000 volume with 1 trade. The average volume for the last 3 months is 20,075 and the stock's 52-week low/high is $0.0495/$0.135.

Recent News

chart

Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF)

The QualityStocks Daily Newsletter would like to spotlight Therma Bright, Inc. (OTC: THRBF).

Medical device innovator Therma Bright (TSX.V: THRM) (OTC: THRBF) is testing its trademarked infrared heat therapy with cannabidiol (“CBD”) to find nonaddictive solutions for general and chronic pain. To view the full press release, visit: http://nnw.fm/3fZF4.

Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF) is a medical device technology provider focused on addressing dermatological needs in the multi-billion-dollar cosmeceutical industry. The company’s effective, non-invasive and pain-free skin care is based on proprietary technology which has received Class II medical device status from the U.S. Food and Drug Administration.

Therma Bright’s portfolio includes products, devices and treatments that have both cosmetic and medicinal or therapeutic benefits, such as for relief of pain, itch and inflammation resulting from more than 20,000 types of insect and marine life bites and stings, including bees, wasps, hornets, mosquitos, black flies and jellyfish.

The Company’s current focus is to market its products online through various social media networks, and to eventually re-establish relationships with major North American and Global retailers.

Products

The company currently has two products on the market and another in the research and development phase:

InterceptCS™ is a thermal therapy device for the treatment and prevention of cold sores caused by the herpes simplex Type 1 virus*. Symptoms typically include sores around the mouth and lips which InterceptCS™ treats by application of controlled topical heat with no risk of burning the skin. When used at the first sign of an oncoming cold sore application of InterceptCS™ can prevent symptoms from developing. Infrared energy and light from the device penetrate the skin killing cells infected with the virus.

InterceptCS™ is available without prescription and comprises a battery powered ergonomic hand-held unit and a disposable single-use treatment activator. Therma Bright has completed prototyping of multi-use activators for InterceptCS™. The company plans to bring to market 5, 10 or 20 multi-use activations at prices that will offer customers greater value than the current single-use activator.

The other Therma Bright product currently under development is TherOZap™, a next generation thermal therapy device powered by the company’s core technology, which is approved by the FDA as a Class II medical device for the relief of the symptoms of insect bites. Therma Bright is testing a new easier-to-use prototype of the device for effectiveness against Zika virus and other diseases carried by mosquitos. Once the technology proves effective, Therma Bright intends to seek regulatory approvals and extend the prototype enhancements to a new commercial version of TherOZap™.

Cannabis

Therma Bright is also conducting research and development on a unique thermal therapy device that would incorporate medical grade cannabis or cannabidiol (“CDB”) sourced from hemp as a cream or gel to provide relief of back, knee and other joint pain. In preparation, the company has incorporated a wholly owned subsidiary to hold any technology for use or application of cannabis. Once approvals are secured, the company plans to sell the device through licensed cannabis producers or retailers across Canada and in international markets where use of cannabis has been legalized. The company has initiated trademark and patent protection for its thermal therapy technology incorporating medical cannabis. Therma Bright has indicated it will seek an acquisition to help further development of this product.

Market Opportunity

A report by market intelligence firm Mordor Intelligence put the global cosmeceuticals market at a value of nearly US$47 billion in 2017 and projects it to be worth more than $80 billion by 2023, growing at a rate of almost 9.5 percent annually. Medical research estimates that somewhere between 20 percent and 40 percent of the population suffer occasional cold sore outbreaks. In Canada those figures would mean five to 10 million people, and in the U.S. some 40 million to 80 million, with recurring cold sores, representing a substantial potential market for Therma Bright.

Management

Rob Fia serves as Therma Bright chairman and CEO. Fia has extensive contacts in the investment community and the financial sector as well as knowledge of various Canadian stock exchange listing processes and requirements. His 18 years in the investment business has included equity research and advising promising early stage companies on corporate finance. Therma Bright CFO Victor Hugo is a senior financial analyst at Marrelli Support Services Inc., for which he provides CFO, accounting, regulatory compliance, and management advisory services to companies listed on the TSX, TSX Venture Exchange and other Canadian and US exchanges.

**Based on double blind placebo study, the InterceptCS™ is approved by Health Canada for the claim “For prevention of cold sores when used within 3 hours of the onset of the prodrome.” The InterceptCS™ is not approved by the United States FDA or any claim of clinical indication, clinical efficacy, and/or cure or prevention of disease.

Therma Bright, Inc. (OTC: THRBF), closed the day's trading session at $0.0099, even for the day. The stock's 52-week low/high is $0.0098/$0.0289.

Recent News

chart

Icon Exploration Inc. (TSX.V: IEX.H)

The QualityStocks Daily Newsletter would like to spotlight Icon Exploration Inc. (IEX.H).

Icon Exploration Inc. (TSXV: IEX.H) ("Icon" or the "Company") announces that it has requested that its common shares be voluntarily delisted from the TSX Venture Exchange ("TSXV"). The common shares are expected to be delisted on or about February 27, 2019. Icon's board of the directors determined that it was in the best interests of the Company and its shareholders to voluntarily delist its common shares from the TSXV and to file a listing application with the Canadian Securities Commission (the "CSE").

Icon Exploration Inc.'s (TSX.V: IEX.H) primary objective is to create a well-diversified company focused on assessing and potentially acquiring targets in the cannabis industry. Icon Exploration recently signed a formal share exchange agreement relating to its proposed acquisition of privately held City View Green (“CVG”), a vertically integrated cannabis company incorporated under the laws of Ontario, Canada. CVG’s application to Health Canada for an Access to Cannabis for Medical Purposes Regulations (“ACMPR”) license is now at the in-depth review stage of the licensing process.

CVG is preparing a 40,000-square-foot growing facility near Toronto to produce pharmaceutical-grade cannabis once its ACMPR license is granted. About half of the facility will initially be outfitted with state-of-the-art LED lighting, HVAC and dehumidification systems, and automation technologies to optimize the quality, safety and consistency of cannabis production. About 4,000 square feet will be devoted to an extraction laboratory featuring an ultra-efficient CO2 supercritical extraction process with plans to include ethanol extraction technology in the future.

Another 4.3 acres remains available for future construction of up to 125,000 square feet of grow and extraction space. Production plans include producing high quality edible products, distillates, and water-soluble products for the rapidly expanding CBD-infused (cannabidiol) beverage market.

Management

Icon and CVG have assembled a talented team that includes a Master Grower with cannabis-industry experience to manage indoor grow operations and an extraction expert whose expertise in developing and launching new products was honed while working in Washington state’s cannabis sector. Having gained experience in the Washington state market the extraction expert has a number of brand ideas and recreational cannabis products that became popular in the Washington market as well as a number of in-licensing branding opportunities available to CVG. CVG has also negotiated an agreement with a private company seeking 37 retail cannabis licenses in Alberta, Canada, that provides a reciprocal exchange of shares, product, shelf space and distribution lines. Early discussions with various entities in Europe to arrange an off-take agreement for CBD oils and extracts are also underway.

Market Opportunity

The Canadian medical cannabis market has steadily been growing with an average 10 percent increase in patients each month. Now that the Canadian federal government has legalized recreational cannabis for adult users nationwide, analysts project a compound annual growth rate of nearly 78 percent from 2018 to 2021, reaching an estimated $3 billion by 2021, ArcView Market Research reports. One study from Deloitte pegged the potential economic impact of legalized medical and recreational marijuana in Canada – including transportation, licensing fees and security – at more than $22 billion over the coming years. Health Canada’s most recent data show that sales of cannabis extracts grew 961 percent in the second quarter of 2017, compared to an 89 percent increase in growth of dried cannabis during the same period.

Icon Exploration Inc. (TSX.V: IEX.H), closed the day's trading session at $0.41, even for the day.

Recent News

chart

Cannabis Strategic Ventures, Inc. (NUGS)

The QualityStocks Daily Newsletter would like to spotlight Cannabis Strategic Ventures, Inc. (NUGS).

Cannabis Strategic Ventures Inc. (OTC: NUGS), a publicly traded corporation that cultivates and partners with brands around the world to build category leaders within the cannabis and CBD marketplace, is utilizing a diverse approach to create profitable opportunities across all corners of the market. While primarily outsourcing personnel solutions, the company also seeks investment opportunities in real estate, cultivation, extraction, distribution, packaging, dispensary operations and branded products within the cannabis marketplace.

Cannabis Strategic Ventures, Inc. (NUGS), headquartered in Los Angeles, California, is focused on supporting entrepreneurial growth within the fast-growing legal cannabis sector. Through a selective portfolio of subsidiaries, Cannabis Strategic Ventures offers outsourced personnel solutions tailor-made to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries and other cannabis marketplace participants. The company also pursues investment opportunities in the areas of real estate, cultivation, extraction, distribution, packaging, dispensary operations, and branded products within the cannabis space.

The legalization of adult-use sales in California is expected to create nearly 99,000 cannabis industry jobs in the state by 2021, representing about a third of all cannabis jobs nationwide, and 146,000 jobs overall when indirect and induced efforts are considered, according to Arcview Market Research. By 2021, direct cannabis industry employment will top 291,500 FTE jobs, with a total employment effect of nearly 414,000 FTEs across all legal cannabis states, according to the report.

Cannabis Strategic Ventures believes its staffing capabilities will be in a similar state of demand. The company in April 2018 completed a definitive agreement to acquire Worldwide Staffing Group, Inc., which booked approximately $1.5 million in revenues in 2017.

Worldwide will operate within Cannabis Strategic Ventures as an independent and separate wholly owned subsidiary providing strictly non-cannabis related employment and staffing services. As Worldwide continues to expand its operations in general clerical and administrative, marketing, accounting, and other verticals, Cannabis Strategic Ventures will leverage the subsidiary’s expertise to expand its business operations further into the cannabis staffing arena, with an emphasis on the California markets.

Cannabis Strategic Ventures’ BudHire™ subsidiary is an outsourced employment service specifically designed to meet the needs of growing cannabis-related business operations, utilizes a proven recruiting formula to match the most qualified candidates to a broad spectrum of cannabis-related jobs. Under the BudHire™ brand, Cannabis Strategic Ventures offers temporary, seasonal, permanent staffing solutions, as well as professional employment organization services and human resources consulting to the cannabis industry.

Cannabis Strategic Ventures portfolio also includes Pure Applied Sciences Inc. and its brand “PureOrganix™,” a line of high quality concentrate, organic and pure cannabis oils that conform with Current Good Manufacturing Practices (cGMP) and meet FDA guidelines for Active Pharmaceuticals Products (API). The acquisition includes all intellectual properties, including formulations and technologies, and related accessories of Pure Applied Sciences.

Cannabis Strategic Ventures Pure Applied Sciences subsidiary, has a cannabis concentrate extraction services agreement with CP Logistics LLC (“CPL”), a wholly owned U.S. subsidiary of Sunniva Inc. (CSE:SNN) (OTCQX:SNNVF). Under this agreement, CPL will perform white label services producing high quality, ultra-purified cannabis extracts out of its Sun-Oil Facility in Cathedral City, California, for Pure Applied Sciences under the Pure Organix brand name.

The management team at Cannabis Strategic Ventures believes there is incredible opportunity to carve-out and control specific industry niches, to create unique cannabis consumer branded products, and to expand into other sub-sectors of the cannabis marketplace.

Cannabis Strategic Ventures, Inc. (NUGS), closed the day's trading session at $1.17, off by 1.68%, on 71,501 volume with 1 trade. The average volume for the last 3 months is 123,003 and the stock's 52-week low/high is $1.02/$5.94.

Recent News

chart

Green Hygienics Holdings Inc. (GRYN)

The QualityStocks Daily Newsletter would like to spotlight Green Hygienics Holdings Inc. (GRYN).

Green Hygienics Holdings Inc. (GRYN) was featured today in the 420 with CNW by CannabisNewsWire. As the marijuana industry has grown and become more widely accepted, many tech companies have introduced new products to enable the cannabis industry. Here are the four major AI products that marijuana businesses are deploying to boost sales and make ecommerce more successful.

Green Hygienics Holdings Inc. (GRYN) is a full-scope, premium cannabis cultivation company targeting the high-end medical and adult-use recreational market. With more than 25 years of experience in agricultural science and innovation, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company will grow by generating revenues from the sales of premium grade cannabis products, developing and licensing valuable IP, making strategic acquisitions, and creating trusted global consumer brands.

The company has integrated and is developing its own IP assets related to proprietary systems and apparatus, software, algorithms and custom-engineered hardware. This provides ultimate efficiencies in a commercially controlled cultivation environment. Utilizing the advantages of hybrid-aeroponics, Green Hygienics creates a sterile growing environment that produces consistent, high-quality product while maintaining the lowest possible carbon footprint. The company utilizes state-of-the-art, quality-controlled commercial cultivation methodology to assure production of pharmaceutical-grade cannabis at much higher yields and greatly reduced costs.

Hybrid-aeroponics produces quality cannabis faster than traditional methods since it doesn’t require natural sunlight or soil and can be operational and produce plants anywhere. Plants grown under aeroponic conditions receive water and nutrients directly to their roots via a fine mist in a controlled environment, dramatically reducing spoilage while keeping the product organic and the environment pest-free. The plants are given the exact amount of nutrients and moisture precisely when needed. Green Hygienics maintains ultimate control over every aspect of this cultivation process, which allows the company to operate with conservation of natural resources in mind. The technology that uses 90-95 percent less water and does not require the use of pesticides or fungicides.

Additionally, the company’s state-of-the-art engineered, controlled environments include electrical, mechanical and HVAC designs that meet mandatory fire and energy codes while improving energy efficiency significantly.

Through these practices, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company continues to develop and incubate software as well as engineer hardware to provide additional control over the commercial cultivation method. The company’s science-based approach reveals any growth anomalies before the human eye can see them. This makes it possible to monitor all facets of production, identify cultivation problems based upon scientific data, and implement immediate corrective action, if needed.

The future of commercial cannabis cultivation hinges on using science to control the growing environment in order to remain competitive and deliver a premium grade of product on a consistent basis. The company holds a competitive advantage through its ability to produce premium cannabis products at a significantly lower cost per gram than direct competitors and others in the cannabis industry.

Innovations within the sector that create efficiencies and successful brands will become highly valued. Green Hygienics and its forward-thinking management team are constantly studying the market dynamics of the cannabis industry in North America and abroad while actively pursuing possible expansion opportunities. The company is headquartered in Las Vegas, Nevada and establishing operations in San Diego, California, targeting the $5 billion California cannabis market.

Green Hygienics Holdings Inc. (GRYN), closed the day's trading session at $0.56, off by 3.45%, on 12,380 volume with 12 trades. The average volume for the last 3 months is 22,790 and the stock's 52-week low/high is $0.05/$0.579.

Recent News

chart

Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN)

The QualityStocks Daily Newsletter would like to spotlight Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN).

Recent supply-side shortages and the resulting tightness in the world’s iron ore market are seen as solid reasons for investors to keep a close eye on Canadian iron ore exploration and development company Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN) as it brings its premium, high-grade iron ore Shymanivske Ukraine project to life. Black Iron’s Shymanivske project is situated in the southern part of the historic KrivBass iron ore mining district, a highly developed iron ore mining region with well-established infrastructure and nearby skilled labor forces. Surrounded by five producing iron ore mines, the Shymanivske project is expected to produce an ultra-high-grade, 68-percent iron ore concentrate with few impurities at very low cost (http://nnw.fm/0he2I). Also today, the company was highlighted

Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN) is a Canadian iron ore exploration and development company advancing to production its wholly owned Shymanivske Iron Ore Project, located in Krivyi Rih, Ukraine. Black Iron’s Shymanivske project is situated in the southern part of the historic KrivBass iron ore mining district, a highly developed iron ore mining region with well-established infrastructure and nearby skilled labor forces. Surrounded by seven producing iron ore mines, the Shymanivske project will produce an ultra-high-grade, 68-percent iron ore concentrate with few impurities at very low cost.

The Market

Iron ore concentrates are one of the essential raw materials used by the steel industry to either make sinter or highly valued pellets. Black Iron’s concentrate can be used in either application and is an ideal source to make pellets since it does not need to be ground finer and contains very few impurities. According to the CRU Group, an internationally recognized top global business intelligence provider and consultancy specializing in commodities, there is a growing global shortage of pellet feed resulting in a supply/demand gap of 133Mt against the current base of approximately 400Mt consumed by 2035. According to a recent report issued by Zion Market Research, the global iron ore pellets market was valued at around US$25.22 billion in 2017 and is expected to reach US$50.12 billion by 2024, growing at a compound annual growth rate (CAGR) of 8.1 percent between 2018 and 2024 (http://nnw.fm/2vaDR).

Countries around the world, most notably China (http://nnw.fm/Je8gs), have instituted regulatory changes to curb polluting emissions from steel mills through numerous methods, including encouraging a shift to higher grade iron feed products such as pellets as less coal needs to be burnt per ton of steel produced.

Shymanivske Project

Black Iron’s Shymanivske’s project, which is expected to produce ultra-high-grade 68 percent iron content pellet feed iron concentrate, is generating significant interest from steel mills and global commodity trading houses. Use of ultra-high-grade 68-percent iron content product in the production of steel is a value-added product to customers since it increases blast furnace productivity and reduces greenhouse gas emissions generated per ton of steel produced.

The project’s proximity to rail lines (1 mile), electrical power (20 miles), sea ports (140 to 260 miles) and a skilled workforce (6 miles) significantly reduces the up-front construction costs and allows for the mine to be built in a phased approach. The Shymanivske project has been ranked by the CRU Group in the lowest position of the business cost curve for pellet feed projects currently under development and as the second lowest in capital intensity (construction capital divided by annual production) within CRU Group’s extensive database (http://nnw.fm/3MXsT). This low-cost position makes the project economics very robust to any shocks in iron ore price while providing a very high return at current and forecast prices.

Black Iron continues to advance its project on several fronts including construction funding and off-take agreements (http://nnw.fm/tQ4g2). Discussions with Ukraine’s Ministry of Defense to transfer a parcel of land required by the company for location of its processing plant, waste rock and tailings are nearing finalization, as are discussions with the Kryviy Rih City Council to lease a portion of the surface rights currently under that body’s control. The recent engagement of Ivan Markovich as Black Iron’s Vice President of Government and Community Relations will assist the company in these endeavors given his extensive network of relationships with senior Ukraine government officials.

The Shymanivske project holds a mining allotment permit for a large iron ore deposit with a NI 43-101 compliant resource estimated to contain 646 Mt (million tons) Measured and Indicated mineral resources, consisting of 355 Mt Measured mineral resources grading 31.6% total iron and 18.8% magnetic iron, and Indicated mineral resources of 290 Mt grading 31.1% total iron and 17.9% magnetic iron, using a cut-off grade of 10% magnetic iron. Additionally, there are 188 Mt of Inferred mineral resources grading 30.1% total iron and 18.4% magnetic iron.

Full mineral resource details and project economics can be found in the NI 43-101 compliant technical report entitled “Preliminary Economic Assessment of the Re-scoped Shymanivske Iron Ore Deposit” effective November 21, 2017, under the Company’s profile on SEDAR at?www.sedar.com.

Management

Black Iron’s management and board of directors is stacked with experts well-versed in successfully building and operating iron ore projects. CEO Matt Simpson, P.Eng. is the former general manager of Mining for Rio Tinto’s Iron Core Company of Canada and worked for Hatch designing global metallurgical refineries. He is also a Qualified Person as defined by NI 43-101. Chairman Bruce Humphrey is the former COO of GoldCorp and former chairman of Consolidated Thompson Iron Ore mines which was sold to Cliff’s resources for US$4.9 billion.

Les Kwasik, COO, has over 40 years of hands-on experience building and operating mines globally with companies such as INCO (VALE) and Xstrata (Glencore). Paul Bozoki, CFO, is the former CFO of CD Capital Partners, operating in the Ukraine. Bill Hart, senior vice president of corporate development, has over 30 years of experience selling iron ore while working for Rio Tinto, Cliffs Natural Resources and most recently Roy Hill Holdings Ltd. Ivan Markovich was recently engaged in the capacity of Black Iron’s vice president of Government and Community Relations to leverage his extensive network of relationships with senior Ukraine government officials.

Black Iron Inc. (BKIRF), closed the day's trading session at $0.0674, off by 17.30%, on 103,409 volume with 14 trades. The average volume for the last 3 months is 24,145 and the stock's 52-week low/high is $0.0285/$0.094.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

Technology and investment company SinglePoint (OTCQB: SING) was featured on this week’s episode of MoneyTV with Donald Baillargeon. To view the full interview, visit http://nnw.fm/R5iUA. To view the full press release, visit: http://nnw.fm/5jtIz.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.0185, off by 1.60%, on 4,230,091 volume with 141 trades. The average volume for the last 3 months is 5,923,344 and the stock's 52-week low/high is $0.0106/$0.0725.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.